Asher  Bearman net worth and biography

Asher Bearman Biography and Net Worth

Insider of Trupanion

Asher joined Trupanion as General Counsel in 2013, after having been Trupanion’s primary outside legal counsel since 2008.

Prior to joining Trupanion, Asher was an attorney with DLA Piper. Asher has a B.A. from the University of Washington, a J.D. from the University of Washington School of Law, and an LL.M. from New York University School of Law. Asher brings more than 10 years of prior legal experience to Trupanion.

Asher lives in West Seattle with his wife, son, and mixed breed puppy, Mouse.

What is Asher Bearman's net worth?

The estimated net worth of Asher Bearman is at least $111,940.00 as of February 25th, 2021. Mr. Bearman owns 3,088 shares of Trupanion stock worth more than $111,940 as of March 29th. This net worth estimate does not reflect any other investments that Mr. Bearman may own. Learn More about Asher Bearman's net worth.

How do I contact Asher Bearman?

The corporate mailing address for Mr. Bearman and other Trupanion executives is 6100 4TH AVENUE SOUTH SUITE 200, SEATTLE WA, 98108. Trupanion can also be reached via phone at (855) 727-9079 and via email at investorrelations@trupanion.com. Learn More on Asher Bearman's contact information.

Has Asher Bearman been buying or selling shares of Trupanion?

Asher Bearman has not been actively trading shares of Trupanion over the course of the past ninety days. Most recently, Asher Bearman sold 108 shares of the business's stock in a transaction on Monday, February 28th. The shares were sold at an average price of $89.62, for a transaction totalling $9,678.96. Learn More on Asher Bearman's trading history.

Who are Trupanion's active insiders?

Trupanion's insider roster includes Asher Bearman (Insider), Michael Doak (Director), Emily Dreyer (SVP, Planning, Insights & Development), Robin Ferracone (Director), Gavin Friedman (EVP), John Gallagher (Executive Vice President of Global Support Services), Dan Levitan (Director), Murray Low (Director), Brenna McGibney (Chief Administration Officer), Tricia Plouf (CFO), Fawwad Qureshi (CFO), Darryl Rawlings (Founder, CEO & Chair of the Board), Howard Rubin (Director), Margaret Tooth (Insider), and Steve Weinrauch (EVP, Veterinary & Product). Learn More on Trupanion's active insiders.

Are insiders buying or selling shares of Trupanion?

During the last year, Trupanion insiders bought shares 1 times. They purchased a total of 20,700 shares worth more than $499,698.00. During the last year, insiders at the financial services provider sold shares 19 times. They sold a total of 72,478 shares worth more than $3,061,347.01. The most recent insider tranaction occured on March, 20th when CEO Margaret Tooth sold 4,000 shares worth more than $148,680.00. Insiders at Trupanion own 5.5% of the company. Learn More about insider trades at Trupanion.

Information on this page was last updated on 3/20/2025.

Asher Bearman Insider Trading History at Trupanion

Asher Bearman Buying and Selling Activity at Trupanion

This chart shows Asher Bearman's buying and selling at Trupanion by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$5k$0$5kTotal Insider BuyingTotal Insider Selling

Trupanion Company Overview

Trupanion logo
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.
Read More

Today's Range

Now: $36.25
Low: $35.78
High: $38.29

50 Day Range

MA: $40.80
Low: $32.40
High: $49.87

2 Week Range

Now: $36.25
Low: $19.69
High: $57.90

Volume

443,337 shs

Average Volume

646,663 shs

Market Capitalization

$1.54 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.7